Patent · US Active

Anti-VEGF antibodies

US7375193B2 · kind B2 · utility

44Cited by
8References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2006
Grant dateMay 20, 2008
Priority date—
Expiry dateSep 29, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.